View in EDS

Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.

Saved in:
Bibliographic Details
Title: Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.
Authors: Prunas O; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Willemsen J; Centre for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Division of Infectious Diseases, Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands., Warren JL; Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT USA., Bont L; Division of Infectious Diseases, Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands., Schwartz JL; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA., Atwell J; Medical Development, Scientific, and Clinical Affairs, Pfizer Vaccines, Pfizer Inc., Collegeville, PA, USA., Begier E; Medical Development, Scientific, and Clinical Affairs, Pfizer Vaccines, Pfizer Inc., Collegeville, PA, USA., Dean N; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA., Hirsch I; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Karron R; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Klugman K; Director of Pneumonia and Pandemic Preparedness Programs, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kramer R; Sanofi Vaccines, Lyon, France., Leidman E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Link-Gelles R; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Nair H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK., Panozzo CA; Clinical Development, Infectious Diseases, Moderna Therapeutics, Cambridge, MA, USA., Pelfrene E; Office of Vaccines and Therapies for Infectious Diseases, European Medicines Agency, Amsterdam, the Netherlands., Simões EAF; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Department of Epidemiology, Colorado School of Public Health and Samshoma Medical Research Inc, Denver, CO, USA., Smith PG; MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK., Srikantiah P; Bill & Melinda Gates Foundation, Seattle, WA, USA., Sundaram ME; Marshfield Clinic Research Institute, Center for Clinical Epidemiology & Population Health, Marshfield, WI, USA., Thindwa D; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA., Vaughn DW; Bill & Melinda Gates Foundation, Seattle, WA, USA., Wilson E; Clinical Development, Infectious Diseases, Moderna Therapeutics, Cambridge, MA, USA., Zar HJ; Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, and SA-Medical Research Council on Child & Adolescent Health University of Cape Town, South Africa., Pitzer VE; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA., Weinberger DM; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA.
Source: Vaccine: X [Vaccine X] 2024 Jun 06; Vol. 19, pp. 100509. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40874090
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Prunas+O%22">Prunas O</searchLink>; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Willemsen+J%22">Willemsen J</searchLink>; Centre for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Division of Infectious Diseases, Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Warren+JL%22">Warren JL</searchLink>; Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Bont+L%22">Bont L</searchLink>; Division of Infectious Diseases, Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schwartz+JL%22">Schwartz JL</searchLink>; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Atwell+J%22">Atwell J</searchLink>; Medical Development, Scientific, and Clinical Affairs, Pfizer Vaccines, Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Begier+E%22">Begier E</searchLink>; Medical Development, Scientific, and Clinical Affairs, Pfizer Vaccines, Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dean+N%22">Dean N</searchLink>; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hirsch+I%22">Hirsch I</searchLink>; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Karron+R%22">Karron R</searchLink>; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Klugman+K%22">Klugman K</searchLink>; Director of Pneumonia and Pandemic Preparedness Programs, Bill & Melinda Gates Foundation, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kramer+R%22">Kramer R</searchLink>; Sanofi Vaccines, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Leidman+E%22">Leidman E</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Link-Gelles+R%22">Link-Gelles R</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Nair+H%22">Nair H</searchLink>; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Panozzo+CA%22">Panozzo CA</searchLink>; Clinical Development, Infectious Diseases, Moderna Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pelfrene+E%22">Pelfrene E</searchLink>; Office of Vaccines and Therapies for Infectious Diseases, European Medicines Agency, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Simões+EAF%22">Simões EAF</searchLink>; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Department of Epidemiology, Colorado School of Public Health and Samshoma Medical Research Inc, Denver, CO, USA.<br /><searchLink fieldCode="AU" term="%22Smith+PG%22">Smith PG</searchLink>; MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.<br /><searchLink fieldCode="AU" term="%22Srikantiah+P%22">Srikantiah P</searchLink>; Bill & Melinda Gates Foundation, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Sundaram+ME%22">Sundaram ME</searchLink>; Marshfield Clinic Research Institute, Center for Clinical Epidemiology & Population Health, Marshfield, WI, USA.<br /><searchLink fieldCode="AU" term="%22Thindwa+D%22">Thindwa D</searchLink>; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Vaughn+DW%22">Vaughn DW</searchLink>; Bill & Melinda Gates Foundation, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+E%22">Wilson E</searchLink>; Clinical Development, Infectious Diseases, Moderna Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zar+HJ%22">Zar HJ</searchLink>; Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, and SA-Medical Research Council on Child & Adolescent Health University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Pitzer+VE%22">Pitzer VE</searchLink>; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Weinberger+DM%22">Weinberger DM</searchLink>; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101748769%22">Vaccine: X</searchLink> [Vaccine X] 2024 Jun 06; Vol. 19, pp. 100509. <i>Date of Electronic Publication: </i>2024 Jun 06 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101748769 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-1362 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225901362%22">25901362 </searchLink><i>NLM ISO Abbreviation: </i>Vaccine X <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40874090
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jvacx.2024.100509
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100509
    Titles:
      – TitleFull: Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Prunas O
      – PersonEntity:
          Name:
            NameFull: Willemsen J
      – PersonEntity:
          Name:
            NameFull: Warren JL
      – PersonEntity:
          Name:
            NameFull: Bont L
      – PersonEntity:
          Name:
            NameFull: Schwartz JL
      – PersonEntity:
          Name:
            NameFull: Atwell J
      – PersonEntity:
          Name:
            NameFull: Begier E
      – PersonEntity:
          Name:
            NameFull: Dean N
      – PersonEntity:
          Name:
            NameFull: Hirsch I
      – PersonEntity:
          Name:
            NameFull: Karron R
      – PersonEntity:
          Name:
            NameFull: Klugman K
      – PersonEntity:
          Name:
            NameFull: Kramer R
      – PersonEntity:
          Name:
            NameFull: Leidman E
      – PersonEntity:
          Name:
            NameFull: Link-Gelles R
      – PersonEntity:
          Name:
            NameFull: Nair H
      – PersonEntity:
          Name:
            NameFull: Panozzo CA
      – PersonEntity:
          Name:
            NameFull: Pelfrene E
      – PersonEntity:
          Name:
            NameFull: Simões EAF
      – PersonEntity:
          Name:
            NameFull: Smith PG
      – PersonEntity:
          Name:
            NameFull: Srikantiah P
      – PersonEntity:
          Name:
            NameFull: Sundaram ME
      – PersonEntity:
          Name:
            NameFull: Thindwa D
      – PersonEntity:
          Name:
            NameFull: Vaughn DW
      – PersonEntity:
          Name:
            NameFull: Wilson E
      – PersonEntity:
          Name:
            NameFull: Zar HJ
      – PersonEntity:
          Name:
            NameFull: Pitzer VE
      – PersonEntity:
          Name:
            NameFull: Weinberger DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 06
              Text: 2024 Jun 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2590-1362
          Numbering:
            – Type: volume
              Value: 19
          Titles:
            – TitleFull: Vaccine: X
              Type: main
ResultId 1